
Report ID: SQMIG25M2074
SkyQuest Technology's Antimicrobial medical textiles market size, share and forecast Report is based on the analysis of market data and Industry trends impacting the global Antimicrobial Medical Textiles Market and the revenue of top companies operating in it. Market Size Data and Statistics are based on the comprehensive research by our Team of Analysts and Industry experts.
Global Antimicrobial Medical Textiles Market size was valued at USD 774.8 million in 2023 and is poised to grow from USD 814.31 million in 2024 to USD 1212.31 million by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).
Growing prevalence of hospital-acquired infections (HAIs), rising emphasis on infection control, increasing awareness regarding hygiene, advancements in antimicrobial coatings, and rising adoption of smart textiles in the healthcare industry are slated to help boost the demand for antimicrobial medical textiles over the coming years.
Growing prevalence of chronic diseases has led to increased rates of hospitalization around the world. Rising number of people in hospitals has also increased the risk of hospital-acquired infections and efforts to control the same are promoting the adoption of antimicrobial medical textiles. Rise in senescent population around the world and their expanding healthcare needs are also favoring the global antimicrobial medical textiles market growth.
Innovations in antimicrobial coatings, such as silver nanoparticles, copper-infused textiles, and natural antimicrobial agents are also forecasted to create new opportunities for antimicrobial medical textile companies going forward. Rising efforts of governments and healthcare establishments to curb the spread of infections are also estimated to promote the demand for antimicrobial medical textiles. Increased awareness regarding hygiene among general consumers, patients, and medical professionals is also expected to create a new business scope for antimicrobial medical textile vendors.
Growing preference for home healthcare and imposition of stringent regulatory guidelines for medical textiles are also predicted to boost the adoption of antimicrobial medical textiles. Rising surgical procedure volumes, extended hospital stays, and quick acceptance of smart textiles in healthcare are also slated to be other factors driving antimicrobial medical textile sales on a global level. However, high costs of production, concerns regarding antimicrobial resistance, challenges in maintaining antimicrobial efficacy over time, and competition from traditional medical textile products are estimated to be key restraints for the global antimicrobial medical textiles industry development across the study period and beyond.
Key Market Attributes
In February 2025, The German Institutes of Textile and Fiber Research (DITF) and Heraeus, a German technology company joined hands to develop new antimicrobial medical textiles. The new textiles are expected to be equipped with Heraeus’ advanced AGXX technology to provide them with antimicrobial capabilities. The novel technology leverages catalytic redox reaction initiated by metallic AGXX particles consisting of silver and ruthenium to provide superior antimicrobial protection that is also quite long-lasting as compared to other alternatives present in the market.
In July 2022, Swiss Precision, a renowned Eco HealthTech apparel brand focusing on the medical industry was launched. The company is known for its innovative copper + natural patented materials that are capable of killing or slowing down the spread of microorganisms. The company has developed washable copper-embedded antimicrobial fabrics that provide comfort of organic materials along with antibacterial, antifungal, and antiviral benefits of copper in them. Swiss Precision is focused on using its unique textile offerings for the production of medical scrubs, uniforms, and accessories for medical professionals and patients around the world.
In July 2022, Medicfibers, startup based in India and incubated by FITT, IIT Delhi collaborated with AIIMS New Delhi to develop a novel antimicrobial solution Viroclog® for textiles. Virovlog is applied on textiles as a coating to offer long-lasting protection against HAIs by reducing virus, bacteria, fungi survival on fabric. The novel coating lowers the surface energy of textiles to reduce the adhesion of microbes to the said textile. The Virclog coating is also claimed to be highly durable and stay effective even after 100 washes as compared to market alternatives available at the time that are only effective up to or less than 50 washes.
REQUEST FOR SAMPLE
Global Antimicrobial Medical Textiles Market size was valued at USD 744 Million in 2023 and is poised to grow from USD 777.48 Million in 2024 to USD 1105.65 Million by 2032, growing at a CAGR of 4.5% during the forecast period (2025-2032).
Antimicrobial medical textile companies should focus on entering emerging markets where healthcare infrastructure development is rising. Collaborations and partnerships are slated to be essential for companies looking to launch innovative antimicrobial medical textiles. North America and Europe are expected to offer best returns for companies as per this global antimicrobial medical textiles market analysis. 'Indorama Ventures Fibers Germany', 'Microban International', 'Dow', 'Mollyflex Srl', 'Noble Biomaterials Inc.', 'BioCote Limited', 'Annovotek LLC', 'Herculite', 'PurThread Technologies', 'Sciessent LLC', 'Quick-Med Technologies Inc.', 'Sinanen Zeomic Co. Ltd.'
Governments as well as regulatory bodies around the world are enforcing strict regulatory guidelines and standards for medical textiles to avoid the risk of infections and cross contamination. Antimicrobial medical textiles comply with such regulations and provide a safe textile alternative for all types of healthcare end users and patients around the world.
Nanotechnology-Based Antimicrobial Textiles: Antimicrobial medical textile companies should focus on utilizing nanotechnology to stand out from the competition. Use of Silver, copper, and zinc oxide nanoparticles can help market players maximize their business scope as they offer long-lasting antimicrobial protection for use in high-risk medical environments and establishments.
North America is estimated to bring in the most revenue for all antimicrobial medical textile companies on a global level. Presence of a developed healthcare infrastructure, quick adoption of advanced medical technologies, and rising surgical procedure volumes are helping this region lead the global antimicrobial medical textile demand outlook.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG25M2074
sales@skyquestt.com
USA +1 351-333-4748